Terms: = Leukemia AND PTPN11, CFC, Q06124, 5781, ENSG00000179295, SHP2, MGC14433, SHP-2, BPTP3, PTP-1D, SH-PTP3, NS1, SH-PTP2, PTP2C
765 results:
1. Triple Trouble.
Diwan A; Barsode S
J Assoc Physicians India; 2024 Mar; 72(3):97-99. PubMed ID: 38736127
[TBL] [Abstract] [Full Text] [Related]
2. Assessment of the FRET-based Teen sensor to monitor ERK activation changes preceding morphological defects in a RASopathy zebrafish model and phenotypic rescue by MEK inhibitor.
Fasano G; Petrini S; Bonavolontà V; Paradisi G; Pedalino C; Tartaglia M; Lauri A
Mol Med; 2024 Apr; 30(1):47. PubMed ID: 38594640
[TBL] [Abstract] [Full Text] [Related]
3. The RAS-signaling-pathway-mutation-related prognosis in B-cell acute lymphoblastic leukemia: A report from South China children's leukemia group.
Li X; Lin S; Liao N; Mai H; Long X; Liu L; Wu B; Chen Q; Kong Q; Kong X; Liu L; Qin J; Fang J; Zhou D
Hematol Oncol; 2024 May; 42(3):e3265. PubMed ID: 38564328
[TBL] [Abstract] [Full Text] [Related]
4. [leukocyte-associated immunoglobulin-like receptor 1 (LAIR-1) inhibits proliferation and promotes apoptosis of human HEL cells with JAK2 V617F mutation by blocking the JAK/STAT and PI3K/AKT signaling pathways].
Fan C; Zhang Y; Yang R; Wu X; Zhou J; Xue J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Mar; 40(3):207-214. PubMed ID: 38512030
[TBL] [Abstract] [Full Text] [Related]
5. [FLT3-ITD mutation-positive acute myeloid leukemia undergoing clonal transition with ptpn11 mutation at relapse].
Kurihara K; Sadato D; Najima Y; Hirama C; Haraguchi K; Kato K; Kondo K; Sadaga Y; Kato C; Sakai S; Kambara Y; Nabe Y; Teshima K; Asano K; Jinguji A; Shimabukuro M; Ouchi F; Inai K; Koi S; Shingai N; Toya T; Shimizu H; Kobayashi T; Oboki K; Harada H; Okuyama Y; Harada Y; Doki N
Rinsho Ketsueki; 2024; 65(2):63-68. PubMed ID: 38447999
[TBL] [Abstract] [Full Text] [Related]
6. [Clinical and prognostic characteristics of pediatric acute myeloid leukemia with myelodysplasia-related changes under different diagnostic criteria].
Zhang RR; Ruan M; Liu TF; Wang SC; Zhang XY; Qi BQ; Zhu XF; Zhang L
Zhonghua Er Ke Za Zhi; 2024 Mar; 62(3):250-255. PubMed ID: 38378287
[No Abstract] [Full Text] [Related]
7. CEBPA double mutations associated with ABO antigen weakness in hematologic diseases.
Choi SJ; Kim HK; Suh EJ; Kwon SS; Shin S; Lee ST; Kim S
Blood Adv; 2024 Mar; 8(6):1487-1493. PubMed ID: 38359363
[TBL] [Abstract] [Full Text] [Related]
8. Activating p53 abolishes self-renewal of quiescent leukaemic stem cells in residual CML disease.
Scott MT; Liu W; Mitchell R; Clarke CJ; Kinstrie R; Warren F; Almasoudi H; Stevens T; Dunn K; Pritchard J; Drotar ME; Michie AM; Jørgensen HG; Higgins B; Copland M; Vetrie D
Nat Commun; 2024 Jan; 15(1):651. PubMed ID: 38246924
[TBL] [Abstract] [Full Text] [Related]
9. Role of Influenza A virus protein ns1 in regulating host nuclear body ND10 complex formation and its involvement in establishment of viral pathogenesis.
Das U; Chawla-Sarkar M; Gangopadhyay SR; Dey S; Sharma RD
PLoS One; 2024; 19(1):e0295522. PubMed ID: 38166085
[TBL] [Abstract] [Full Text] [Related]
10. Noonan Syndrome-related Myeloproliferative Disorder Occurring in the Neonatal Period: Case Report and Literature Review.
Hoshino Y; Moriya K; Mitsui-Sekinaka K; Hashimoto Y; Nakayama S; Sajiki D; Muramatsu H; Hagiwara H; Suzuki S; Sekinaka Y; Wakamatsu H; Kawaguchi H; Imai K
J Pediatr Hematol Oncol; 2024 Mar; 46(2):e176-e179. PubMed ID: 38132703
[TBL] [Abstract] [Full Text] [Related]
11. JC-010a, a novel selective shp2 allosteric inhibitor, overcomes RTK/non-RTK-mediated drug resistance in multiple oncogene-addicted cancers.
Lu X; Yu R; Li Z; Yang M; Dai J; Liu M
Cancer Lett; 2024 Feb; 582():216517. PubMed ID: 38101609
[TBL] [Abstract] [Full Text] [Related]
12. Allosteric shp2 inhibition increases apoptotic dependency on BCL2 and synergizes with venetoclax in FLT3- and KIT-mutant AML.
Popescu B; Stahlhut C; Tarver TC; Wishner S; Lee BJ; Peretz CAC; Luck C; Phojanakong P; Camara Serrano JA; Hongo H; Rivera JM; Xirenayi S; Chukinas JA; Steri V; Tasian SK; Stieglitz E; Smith CC
Cell Rep Med; 2023 Nov; 4(11):101290. PubMed ID: 37992684
[TBL] [Abstract] [Full Text] [Related]
13. Genomic Mutation Profiles of Patients with Acute Myeloid leukemia in Korea: a Single-Center Experience.
Han E; Ryu S; Kim D; Koh EH; Byun JH; Lee DH
Clin Lab; 2023 Nov; 69(11):. PubMed ID: 37948498
[TBL] [Abstract] [Full Text] [Related]
14. Biallelic inactivation of the NF1 tumour suppressor gene in juvenile myelomonocytic leukaemia: Genetic evidence of driver function and implications for diagnostic workup.
Ramamoorthy S; Lebrecht D; Schanze D; Schanze I; Wieland I; Andrieux G; Metzger P; Hess M; Albert MH; Borkhardt A; Bresters D; Buechner J; Catala A; De Haas V; Dworzak M; Erlacher M; Hasle H; Jahnukainen K; Locatelli F; Masetti R; Stary J; Turkiewicz D; Vinci L; Wlodarski MW; Yoshimi A; Boerries M; Niemeyer CM; Zenker M; Flotho C
Br J Haematol; 2024 Feb; 204(2):595-605. PubMed ID: 37945316
[TBL] [Abstract] [Full Text] [Related]
15. The clinical features and prognostic implications of ptpn11 mutation in adult patients with acute myeloid leukemia in China.
Yang J; Zhao L; Wu Y; Niu T; Gong Y; Chen X; Huang X; Liu J; Dai Y; Ma H
Cancer Med; 2023 Dec; 12(23):21111-21117. PubMed ID: 37937729
[TBL] [Abstract] [Full Text] [Related]
16. Long-Term Stability of Cord Blood Units After 29 Years of Cryopreservation: Follow-Up Data From the José Carreras Cord Blood Bank.
Liedtke S; Többen S; Gressmann H; Meyer A; Verde PE; Gluckman E; Kogler G
Stem Cells Transl Med; 2024 Jan; 13(1):30-42. PubMed ID: 37936262
[TBL] [Abstract] [Full Text] [Related]
17. Genomic alterations in blast phase of BCR::ABL1-negative myeloproliferative neoplasms.
Chen D; Weinberg OK
Int J Lab Hematol; 2023 Dec; 45(6):839-844. PubMed ID: 37867386
[TBL] [Abstract] [Full Text] [Related]
18. Celastrol attenuates human parvovirus B19 ns1‑induced NLRP3 inflammasome activation in macrophages.
Huang CL; Chen DY; Tzang CC; Lin JW; Tzang BS; Hsu TC
Mol Med Rep; 2023 Oct; 28(4):. PubMed ID: 37654202
[TBL] [Abstract] [Full Text] [Related]
19. Acute megakaryoblastic leukaemia shows high frequency of chromosome 1q aberrations and dismal outcome.
Pastore F; Gittinger H; Raab S; Tschuri S; Ksienzyk B; Konstandin NP; Schneider S; Rothenberg-Thurley M; Horny HP; Werner M; Sauerland MC; Amler S; Görlich D; Berdel WE; Wörmann B; Braess J; Hiddemann W; Tischer J; Herold T; Metzeler KH; Spiekermann K
Br J Haematol; 2023 Sep; 202(6):1165-1177. PubMed ID: 37455345
[TBL] [Abstract] [Full Text] [Related]
20. Protein Tyrosine Phosphatase Non-Receptor 11 (
Richards CE; Elamin YY; Carr A; Gately K; Rafee S; Cremona M; Hanrahan E; Smyth R; Ryan D; Morgan RK; Kennedy S; Hudson L; Fay J; O'Byrne K; Hennessy BT; Toomey S
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445722
[No Abstract] [Full Text] [Related]
[Next]
